本文關(guān)鍵詞：內(nèi)障病主方治療濕性年齡相關(guān)性黃斑變性（脈絡(luò)郁阻型）的療效評(píng)價(jià)　出處：《河南中醫(yī)藥大學(xué)》2016年碩士論文　論文類型：學(xué)位論文

  更多相關(guān)文章： WAMD 內(nèi)障病主方 丹紅化瘀口服液 脈絡(luò)郁阻型

【摘要】：目的:本課題以中醫(yī)理論為指導(dǎo),在導(dǎo)師臨床經(jīng)驗(yàn)的指導(dǎo)下,通過(guò)對(duì)患者治療過(guò)程中臨床證候的觀察及視力、FFA、OCT客觀指標(biāo)的測(cè)定,觀察濕性年齡相關(guān)性黃斑變性(脈絡(luò)郁阻型)患者用內(nèi)障病主方治療的綜合療效。為中醫(yī)藥治療該病提供科學(xué)依據(jù)。方法:將確診為WAMD脈絡(luò)郁阻型的患者60例(79只眼),隨機(jī)分為治療組和對(duì)照組各30例;其中治療組(40只眼)口服內(nèi)障病主方,對(duì)照組(39只眼)口服丹紅化瘀口服液。兩組均按規(guī)定用藥,詳細(xì)觀察治療組與對(duì)照組治療前后患者的視力、眼底、FFA、OCT及全身情況的變化。結(jié)果:(1)綜合療效方面:治療組30例中總有效率93.3%,對(duì)照組中總有效率66.7%,(P=0.0330.05)有統(tǒng)計(jì)學(xué)意義,說(shuō)明內(nèi)障病主方治療脈絡(luò)郁阻型WAMD的綜合療效優(yōu)于對(duì)照組。(2)中醫(yī)證候方面:治療組的30例中總有效率86.7%,對(duì)照組的30例中總有效率66.7%,(P0.05)有顯著差異,表明治療組療效優(yōu)于對(duì)照組。(3)視力方面:治療后兩組視力均有提升,治療前兩組視力比較的結(jié)果(P=0.0850.05),無(wú)統(tǒng)計(jì)學(xué)意義,有可比性。(4)眼底方面:治療組有效率為92.5%,對(duì)照組有效率為71.8%,兩組經(jīng)比較(P=0.0200.05),表明治療組好于對(duì)照組。(5)OCT方面:治療組40只眼中總有效率87.5%。對(duì)照組39只眼中總有效率87.2%。(P=0.0310.05)有統(tǒng)計(jì)學(xué)意義。結(jié)論:(1)內(nèi)障病主方能改善脈絡(luò)郁阻型濕性年齡相關(guān)性黃斑變性患者的臨床癥狀,提高視力,促進(jìn)眼底玻璃膜疣、出血的吸收;(2)內(nèi)障病主方具有開郁活血,通竅明目之功效,在治療濕性年齡相關(guān)性黃斑變性脈絡(luò)郁阻型時(shí),能明顯改善患者的體質(zhì),對(duì)疾病起到治療及預(yù)防作用;(3)內(nèi)障病主方對(duì)脈絡(luò)郁阻型的濕性年齡相關(guān)性黃斑變性患者在治療方面,其療效明顯優(yōu)于國(guó)藥準(zhǔn)字的丹紅化瘀口服液;(4)內(nèi)障病主方服用安全有效,且易患者接受,有較好的社會(huì)經(jīng)濟(jì)效益。
[Abstract]:Objective: This study is based on Chinese medicine theory, in under the guidance of my tutor's clinical experience, through observation and vision, of course of treatment and clinical syndromes in patients with FFA, OCT determination of objective index to observe the wet age-related macular degeneration (choroid obstructing type) with cataract disease and comprehensive curative effect of treatment of patients. For traditional Chinese medicine to provide a scientific basis for treatment of the disease. Methods: the diagnosis of WAMD type of context Yu resistance in 60 patients (79 eyes), were randomly divided into treatment group and control group with 30 cases in each group; the treatment group (40 eyes) of cataract and oral disease, control group (39 eyes) with red blood oral liquid. Two groups were prescribed medication, with observation of treatment group and control group before and after treatment in patients with visual acuity, fundus changes, FFA, OCT and systemic conditions. Results: (1) the comprehensive curative effect: 30 cases in treatment group, the total efficiency of 93.3% in the control group, the total efficiency of 66.7% (P=0.0330.05). A system 璁″鎰忎箟,璇存槑鍐呴殰鐥呬富鏂規(guī)不鐤楄剦緇滈儊闃誨瀷WAMD鐨勭患鍚堢枟鏁堜紭浜庡鐓х粍.(2)涓尰璇佸，

本文編號(hào)：1437940